Treatment of pelvic nodes individualized by inclusion of sentinel nodes is feasible with IMRT, says
(European Association of Urology) Treatment of pelvic nodes individualized by inclusion of sentinel nodes can be easily integrated into an IMRT-based treatment strategy, according to the new study conducted by a group of researchers from Tübingen and Munich in Germany. The target volume concept seems to correctly cover individual pelvic nodes, which is indicated by the absence of any nodal recurrence within five years of follow-up. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 15, 2013 Category: Global & Universal Source Type: news

Financial interests ‘driving IMRT uptake for prostate cancer’
A study suggests that the recent rapid uptake of intensity-modulated radiotherapy for prostate cancer in the USA has been driven by urologists with financial conflicts of interest. (Source: MedWire News - Urology)
Source: MedWire News - Urology - November 6, 2013 Category: Urology & Nephrology Source Type: news

Urologists Follow the IMRT Money in Prostate CancerUrologists Follow the IMRT Money in Prostate Cancer
A study in the New England Journal of Medicine indicates that urologists' use of IMRT jumps significantly once a urology practice acquires IMRT services and can get reimbursed for them. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NEJM: Urologist self-referral equals IMRT overuse
Allowing urologists to self-refer patients for intensity-modulated radiation (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2013 Category: Radiology Source Type: news

NEJM study exposes overuse of radiation therapy when urologists profit from self-referral
(American Society for Radiation Oncology) A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity- modulated radiation therapy for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral, according to new research, "Urologists' Use of Intensity- Modulated Radiation Therapy for Prostate Cancer," released today in The New England Journal of Medicine for its October 24, 2013 issue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2013 Category: Global & Universal Source Type: news

Advanced form of proton therapy reduces need for feeding tubes by 50 percent
A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat. The results, presented by the lead researcher, Steven J. Frank, M.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 29, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Department of Health earmarks another £30m for cancer
The machines are capable of delivering both standard radiotherapy and intensity modulated radiation therapy (IMRT), which is a particularly important form of treatment for head and neck cancers because it can be used to target the tumour more precisely, meaning there are fewer side-effects for patients. This can help improve the patient’s quality of life after treatment and save lives. (Source: NHS Networks)
Source: NHS Networks - August 27, 2013 Category: UK Health Authors: Karen Topping Source Type: news

Conflict-of-Interest Seen in Some Prescribing Radiotherapy for Prostate Cancer (FREE)
By Joe Elia The number of self-referrals for intensity-modulated radiation therapy (IMRT) of prostate cancer has increased in the U.S. in recent years, while use of this treatment has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 20, 2013 Category: Primary Care Source Type: news

GAO report points to prostate cancer IMRT self-referral
A new report published by the U.S. Government Accountability Office (GAO) has (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 2, 2013 Category: Radiology Source Type: news

Seeking A Less Toxic Radiation Treatment For HPV-Positive Oropharynx Cancer
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings were presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Researchers investigate a less toxic radiation treatment for HPV-Positive oropharynx cancer
(Fox Chase Cancer Center) Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 30, 2013 Category: Global & Universal Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - May 28, 2013 Category: Cancer & Oncology Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 28, 2013 Category: Cancer & Oncology Source Type: news

IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Urology)
Source: MedWire News - Urology - May 27, 2013 Category: Urology & Nephrology Source Type: news

IMRT Benefits in Prostate Cancer Questioned (CME/CE)
(MedPage Today) -- Men with prostate cancer gained no obvious benefits from treatment with intensity-modulated radiation therapy (IMRT) as compared with an older, less expensive technique, an analysis of a government database suggests. (Source: MedPage Today Urology)
Source: MedPage Today Urology - May 21, 2013 Category: Urology & Nephrology Source Type: news